Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Research validates family history screening questionnaire as tool to cover multiple conditions

The family history screening questionnaire can be used to provide insight into people's susceptibility to breast, ovarian, bowel and prostate cancer, melanoma, ischaemic heart disease and type 2 diabetes.

22 May 2014

Robot-assisted surgery for removing cancerous prostate glands as safe as open surgery, but expensive

Minimally invasive robot-assisted surgery, which has become the main choice for surgically removing cancerous prostate glands during recent years, is as safe as open surgery for Medicare patients over age 65.

20 May 2014

Norris Cotton Cancer Center receives 3 year term of accreditation from ACR

The American College of Radiology (ACR) has awarded a three-year term of accreditation to Norris Cotton Cancer Center's (NCCC) Radiation Oncology department after a complete review and on-site surveys of its professional and technical practices and facilities in Lebanon, New Hampshire and St. Johnsbury, Vermont.

20 May 2014

Registration now open for interactive one day workshop for GPs

Registration is now open for an interactive one day workshop in Brisbane, designed by GPs for GPs, that will cover five hot topics — including statin prescribing and whether the hype is justified on newer oral anticoagulants.

19 May 2014

Low risk prostate cancer not always low risk

More and more men who believe they have low-risk prostate cancers are opting for active surveillance, forgoing treatment and monitoring the cancer closely with prostate-specific antigen (PSA) tests, digital rectal exams and ultrasounds at regular intervals to see if their tumors are growing. Nearly 400 men are now enrolled in the UCLA Active Surveillance program, the largest in Southern California.

19 May 2014

Dogs accurately detect prostate cancer

With an accuracy rating of 98 percent, specially-trained dogs were able to smell volatile organic compounds (VOCs) released into urine by prostate tumors, setting the stage for a potentially new means of early prostate cancer detection.

19 May 2014

Specific Technologies unveils SpecID blood culture system at General Meeting of the American Society for Microbiology

Specific Technologies, developer of the SpecID™ system to rapidly detect and identify bacterial species and strain via a metabolomic fingerprint, today announced that for the first time it will showcase its transformative SpecID blood culture system at the 114th General Meeting of the American Society for Microbiology, May 17-20, 2014 in Boston, Massachusetts at the Boston Convention and Exhibition Center.

16 May 2014

TOLMAR Pharmaceuticals holds exclusive distribution rights to ELIGARD in the U.S. and Puerto Rico

TOLMAR Pharmaceuticals, Inc., focused on specialty pharmaceutical products, today announced that, effective May 8, 2014, the company holds exclusive distribution rights to ELIGARD® (leuprolide acetate for injectable suspension) in the U.S. and Puerto Rico.

16 May 2014

VisionGate develops LuCED test for early detection of lung cancer

VisionGate Inc., an in vitro diagnostics company that is developing a revolutionary, non-invasive test for the early detection of lung cancer and other applications, announced that positive results from a clinical study of its LuCED lung test will be highlighted in a poster presentation (Abstract #7547) during the American Society of Clinical Oncology (ASCO) 2014 Annual Meeting at McCormick Place in Chicago on Saturday, May 31, 1:15 to 5 p.m. in S Hall A2, poster board 155.

15 May 2014

Heart Failure Association calls for global policy change relating to heart failure

The Heart Failure Association of the European Society of Cardiology is calling for global policy change relating to heart failure. An international white paper, Heart failure: preventing disease and death worldwide, will be presented at an endorsement event on 16 May 2014 in Athens, Greece, immediately before the Heart Failure 2014 Congress.

14 May 2014

Interactive multimedia computer program fails to increase colorectal cancer screening rates

Colorectal cancer screening saves lives, but too few people get tested. In an effort to increase these numbers,researchers from UC Davis and elsewhere investigated whether an individualized interactive multimedia computer program (IMCP) would spur patients to get screened.

14 May 2014

Scientists identify two new genes that lead to more aggressive forms of prostate cancer

A study by the Columbia University Nova York, in collaboration with the Catalan Institute of Oncology , Belvitge Biomedical Research Institute (ICO-IDIBELL) has identified two new genes that lead to more aggressive forms of prostate cancer.

14 May 2014

Treating older men with early-stage prostate cancer does not help live longer

Treating older men with early-stage prostate cancer who also have other serious underlying health problems with aggressive therapies such as surgery or radiation therapy does not help them live longer and, in fact, can be detrimental, according to a study by UCLA researchers.

13 May 2014

2 genes work together to drive most lethal forms of prostate cancer

Two genes work together to drive the most lethal forms of prostate cancer, according to new research from the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center (CUMC).

13 May 2014

Inovio Pharmaceuticals reports total revenue of $2.4 million for first quarter 2014

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2014.

12 May 2014

ImaginAb announces completion of $21M Series B financing

ImaginAb, Inc., a clinical stage biotechnology company that engineers antibodies into smaller protein formats optimized for in vivo molecular imaging, announced today the completion of a $21M Series B financing of the company, led by Mérieux Développement and syndicated with Novartis Venture Funds, Cycad Group and Nextech Invest.

9 May 2014

MRI-guided focused ultrasound to treat pain from bone metastases

InSightec Ltd, the leader in magnetic resonance imaging guided Focused Ultrasound therapy (MRgFUS), announced that the results of its ExAblate® Phase III clinical trial for treating painful bone metastases have been published online in the JNCI, Journal of National Cancer Institute.

8 May 2014

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Janssen R&D Ireland Ltd. (Janssen) today announced that it has expanded its collaboration with the International Partnership for Microbicides (IPM) for the development and delivery of dapivirine (TMC120) for the prevention of HIV.

8 May 2014

ArQule reports net loss of $7,141,000 in first quarter 2014

ArQule, Inc. today announced its financial results for the first quarter of 2014. For the quarter ended March 31, 2014, the Company reported a net loss of $7,141,000 or $0.11 per share, compared to a net loss of $5,775,000, or $0.09 per share, for the first quarter of 2013.

7 May 2014

NCCN publishes new patient resource for stage 0 breast cancer

The National Comprehensive Cancer Network (NCCN), with the support of the NCCN Foundation®, announces the availability of the NCCN Guidelines for Patients: Breast Cancer Stages 0 - IV—the latest addition to the library of NCCN Guidelines for Patients available online free-of-charge at NCCN.org/patients.

6 May 2014

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Research validates family history screening questionnaire as tool to cover multiple conditions

Robot-assisted surgery for removing cancerous prostate glands as safe as open surgery, but expensive

Norris Cotton Cancer Center receives 3 year term of accreditation from ACR

Registration now open for interactive one day workshop for GPs

Low risk prostate cancer not always low risk

Dogs accurately detect prostate cancer

Specific Technologies unveils SpecID blood culture system at General Meeting of the American Society for Microbiology

TOLMAR Pharmaceuticals holds exclusive distribution rights to ELIGARD in the U.S. and Puerto Rico

VisionGate develops LuCED test for early detection of lung cancer

Heart Failure Association calls for global policy change relating to heart failure

Interactive multimedia computer program fails to increase colorectal cancer screening rates

Scientists identify two new genes that lead to more aggressive forms of prostate cancer

Treating older men with early-stage prostate cancer does not help live longer

2 genes work together to drive most lethal forms of prostate cancer

Inovio Pharmaceuticals reports total revenue of $2.4 million for first quarter 2014

ImaginAb announces completion of $21M Series B financing

MRI-guided focused ultrasound to treat pain from bone metastases

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

ArQule reports net loss of $7,141,000 in first quarter 2014

NCCN publishes new patient resource for stage 0 breast cancer

What to know about prostate cancer eBook

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in